<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08588009045199</udiDi>
    <basicUdiDi>8588009045HYPROMELOZAPR3</basicUdiDi>
    <tradeName>HYPROMELOZA-P® oční kapky, roztok</tradeName>
    <deviceName>HYPROMELOZA-P eye drops, solution</deviceName>
    <manufacturerName>Unimed Pharma spol. s r.o.</manufacturerName>
    <manufacturerSrn>SK-MF-000003111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-31T20:11:56.386Z</lastUpdated>
  </row>
  <row>
    <udiDi>08025288002760</udiDi>
    <basicUdiDi>B-08025288002760</basicUdiDi>
    <tradeName>Eumill</tradeName>
    <deviceName>Eumill Gocce Oculari</deviceName>
    <manufacturerName>Recordati Industria Chimica e Farmaceutica S.p.A</manufacturerName>
    <manufacturerSrn>IT-MF-000012326</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11205500</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:55:19.285Z</lastUpdated>
  </row>
  <row>
    <udiDi>05907572580600</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Cornesin Masc</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO070</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:21:00.349Z</lastUpdated>
  </row>
  <row>
    <udiDi>05212001123892</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Hyal plus 0.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS225</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:20:55.540Z</lastUpdated>
  </row>
  <row>
    <udiDi>05907572580495</udiDi>
    <basicUdiDi>803413527TD067STNCPHTHLSC</basicUdiDi>
    <tradeName>Hialag</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO066</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:10:00.666Z</lastUpdated>
  </row>
  <row>
    <udiDi>05213010813453</udiDi>
    <basicUdiDi>803413527THENOPHTHLMCGLST</basicUdiDi>
    <tradeName>Helenvision Balance</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DEX042</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:09:47.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>05212001113893</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>HYAL 0.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS222</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:09:32.363Z</lastUpdated>
  </row>
  <row>
    <udiDi>05212001102163</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Edenight</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO057</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-31T19:09:32.356Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105105</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.4mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-31T15:51:13.071Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100254</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-1.0mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T15:51:12.269Z</lastUpdated>
  </row>
  <row>
    <udiDi>06251151002960</udiDi>
    <basicUdiDi>6251151Q029-003PG</basicUdiDi>
    <tradeName>i ViVA Plus Eye Drops</tradeName>
    <deviceName>i ViVA Plus Eye Drops</deviceName>
    <manufacturerName>Amman Pharmaceutical Industries</manufacturerName>
    <manufacturerSrn>JO-MF-000032053</manufacturerSrn>
    <authorisedRepresentativeName>Easy Medical Device</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000011902</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>070310005</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-31T14:31:00.535Z</lastUpdated>
  </row>
  <row>
    <udiDi>05905043020921</udiDi>
    <basicUdiDi>5905043OCUHYGXD</basicUdiDi>
    <tradeName>OCU HYGIENE®  Płyn do higieny skóry powiek</tradeName>
    <deviceName>OCU HYGIENE®  Płyn do higieny skóry powiek</deviceName>
    <manufacturerName>FLOSLEK Sp. z o. o.</manufacturerName>
    <manufacturerSrn>PL-MF-000034394</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FL0156</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-31T10:57:40.652Z</lastUpdated>
  </row>
  <row>
    <udiDi>05900257102685</udiDi>
    <basicUdiDi>5900257LTDR52</basicUdiDi>
    <tradeName>LACRIMAL</tradeName>
    <deviceName>LACRIMAL</deviceName>
    <manufacturerName>Zakłady Farmaceutyczne Polpharma SA</manufacturerName>
    <manufacturerSrn>PL-MF-000010601</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LTDR-0500-000</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-31T09:41:32.720Z</lastUpdated>
  </row>
  <row>
    <udiDi>05050474755123</udiDi>
    <basicUdiDi>5050474a000679Y</basicUdiDi>
    <tradeName>HEALON DUET PRO II</tradeName>
    <deviceName>HEALON DUET PRO II</deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10301016</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:58:40.498Z</lastUpdated>
  </row>
  <row>
    <udiDi>05050474755109</udiDi>
    <basicUdiDi>5050474a000669W</basicUdiDi>
    <tradeName>HEALON ENDOCOAT PRO</tradeName>
    <deviceName>HEALON ENDOCOAT PRO</deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10301012</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:58:39.706Z</lastUpdated>
  </row>
  <row>
    <udiDi>04950055603977</udiDi>
    <basicUdiDi>49500551090PN</basicUdiDi>
    <tradeName>cleadew MPS</tradeName>
    <deviceName>cleadew MPS</deviceName>
    <manufacturerName>OPHTECS Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000014564</manufacturerSrn>
    <authorisedRepresentativeName>OPHTECS Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000011893</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>72000</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:27:06.337Z</lastUpdated>
  </row>
  <row>
    <udiDi>04950055603793</udiDi>
    <basicUdiDi>49500551040P7</basicUdiDi>
    <tradeName>cleadew</tradeName>
    <deviceName>cleadew</deviceName>
    <manufacturerName>OPHTECS Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000014564</manufacturerSrn>
    <authorisedRepresentativeName>OPHTECS Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000011893</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>75050</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:27:05.516Z</lastUpdated>
  </row>
  <row>
    <udiDi>04950055501341</udiDi>
    <basicUdiDi>49500551010NW</basicUdiDi>
    <tradeName>Teare W</tradeName>
    <deviceName>Teare W</deviceName>
    <manufacturerName>OPHTECS Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000014564</manufacturerSrn>
    <authorisedRepresentativeName>OPHTECS Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000011893</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>74201</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:27:04.721Z</lastUpdated>
  </row>
  <row>
    <udiDi>04950055206253</udiDi>
    <basicUdiDi>49500551110P3</basicUdiDi>
    <tradeName>cleadew SLi</tradeName>
    <deviceName>cleadew SLi</deviceName>
    <manufacturerName>OPHTECS Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000014564</manufacturerSrn>
    <authorisedRepresentativeName>OPHTECS Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000011893</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>75221</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:27:00.723Z</lastUpdated>
  </row>
  <row>
    <udiDi>04950055206208</udiDi>
    <basicUdiDi>49500551120P6</basicUdiDi>
    <tradeName>cleadew GP hydra one</tradeName>
    <deviceName>cleadew GP hydra one</deviceName>
    <manufacturerName>OPHTECS Corporation</manufacturerName>
    <manufacturerSrn>JP-MF-000014564</manufacturerSrn>
    <authorisedRepresentativeName>OPHTECS Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000011893</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>72100</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:26:59.936Z</lastUpdated>
  </row>
</eudamedExport>